Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edith Uetz-von Allmen

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Vaccine|November 18, 2005
Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cellsYing Waeckerle-Men, Edith Uetz-von Allmen, Bruno Gander, et al.
The Prostate|March 9, 2005
Dendritic cells generated from patients with androgen-independent prostate cancer are not impaired in migration and T-cell stimulationYing Waeckerle-Men, Edith Uetz-von Allmen, Roger von Moos, et al.
Frontiers in Immunology|October 2, 2019
Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7Astrid S Jørgensen, Olav Larsen, Edith Uetz-von Allmen, et al.
Cancer Immunology, Immunotherapy : CII|April 14, 2006
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinomaYing Waeckerle-Men, Edith Uetz-von Allmen, Markus Fopp, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Vaccine|November 18, 2005
Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cellsYing Waeckerle-Men, Edith Uetz-von Allmen, Bruno Gander, et al.
The Prostate|March 9, 2005
Dendritic cells generated from patients with androgen-independent prostate cancer are not impaired in migration and T-cell stimulationYing Waeckerle-Men, Edith Uetz-von Allmen, Roger von Moos, et al.
Frontiers in Immunology|October 2, 2019
Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7Astrid S Jørgensen, Olav Larsen, Edith Uetz-von Allmen, et al.
Cancer Immunology, Immunotherapy : CII|April 14, 2006
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinomaYing Waeckerle-Men, Edith Uetz-von Allmen, Markus Fopp, et al.
Pageof 2